-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Trade Alert: The Founder Of EuroEyes International Eye Clinic Limited (HKG:1846), Jörn Jörgensen, Has Just Spent HK$383k Buying A Few More Shares
Trade Alert: The Founder Of EuroEyes International Eye Clinic Limited (HKG:1846), Jörn Jörgensen, Has Just Spent HK$383k Buying A Few More Shares
Whilst it may not be a huge deal, we thought it was good to see that the EuroEyes International Eye Clinic Limited (HKG:1846) Founder, Jörn Jörgensen, recently bought HK$383k worth of stock, for HK$6.96 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.
See our latest analysis for EuroEyes International Eye Clinic
The Last 12 Months Of Insider Transactions At EuroEyes International Eye Clinic
In fact, the recent purchase by Founder Jörn Jörgensen was not their only acquisition of EuroEyes International Eye Clinic shares this year. Earlier in the year, they paid HK$11.63 per share in a HK$2.6m purchase. That means that even when the share price was higher than HK$6.74 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
In the last twelve months EuroEyes International Eye Clinic insiders were buying shares, but not selling. The average buy price was around HK$8.82. I'd consider this a positive as it suggests insiders see value at around the current price. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
SEHK:1846 Insider Trading Volume July 12th 2022There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership of EuroEyes International Eye Clinic
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own about HK$1.2b worth of shares (which is 55% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?
The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest EuroEyes International Eye Clinic insiders are well aligned, and quite possibly think the share price is too low. Nice! Of course, the future is what matters most. So if you are interested in EuroEyes International Eye Clinic, you should check out this free report on analyst forecasts for the company.
Of course EuroEyes International Eye Clinic may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
雖然這可能不是什麼大事,但我們認為很高興看到歐洲眼國際眼科診所有限公司(HKG:1846)創辦人JöRn Jörgensen最近以每股6.96港元的價格購入價值38.3萬港元的股票。儘管如此,他們的持股比例只增加了很小一部分,從絕對值來看,這也不是大規模收購。
查看我們對歐洲眼國際眼科診所的最新分析
歐洲眼國際眼科診所最近12個月的內幕交易
事實上,創始人JöRn Jörgensen最近的收購併不是他們今年唯一一次收購Euroyes國際眼科診所的股票。今年早些時候,他們以每股11.63港元的價格收購了260萬港元。這意味着,即使股價高於6.74港元(最近的價格),也有內部人士想要購買股票。儘管他們的觀點可能在收購後發生了變化,但這至少表明他們對公司的未來充滿信心。對我們來説,考慮內部人士為股票支付的價格非常重要。一般來説,如果內部人士以高於當前價格的價格買入一隻股票,我們對這隻股票的看法會更積極,因為這表明他們認為這隻股票很有價值,即使價格更高。
在過去的12個月裏,歐洲眼國際眼科診所的內部人士在買入股票,但沒有賣出。平均買入價約為8.82港元。我認為這是積極的,因為它表明內部人士認為價值在當前價格附近。你可以在下面看到過去12個月(由公司和個人)進行的內幕交易的直觀描述。如果你點擊圖表,你可以看到所有的個人交易,包括股票價格、個人和日期!
聯交所:2022年7月12日內幕交易量1,846內部人士總是在買入大量股票。因此,如果這適合你的風格,你可以逐一檢查每一種庫存,或者你可以看看這個免費公司名單。(提示:內部人士一直在買入這些股票)。
歐洲眼國際眼科診所的內部人所有權
我喜歡看內部人士在一家公司持有多少股份,以幫助我瞭解他們與內部人士的關係。通常,內部人持股越高,內部人就越有可能受到激勵,建立長期的公司。Euroyes International Eye Clinic內部人士持有價值約12億港元的股份(佔該公司55%的股份)。我喜歡看到這種程度的內部人持股,因為它增加了管理層考慮股東最佳利益的機會。
歐洲眼國際眼科診所的內幕交易可能告訴我們什麼?
最近的內部收購令人振奮。對過去一年交易的分析也給了我們信心。再加上值得注意的內部人士持股,這些因素表明,歐洲眼國際眼科診所的內部人士非常一致,很可能認為股價太低了。好的!當然了,未來才是最重要的。所以,如果你對歐洲眼國際眼科診所感興趣,你應該去看看這個免費分析師對該公司的預測報告。
當然了歐洲眼國際眼科診所可能不是最值得買入的股票。所以你可能想看看這個免費彙集了高質量的公司。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧